Skip to search formSkip to main contentSkip to account menu

RS 49014

Known as: RS-49014 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

tazifylline

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
Antiallergic effects of the new histamine H1-receptor antagonist tazifylline in healthy atopic and non-atopic subjects.
Single oral doses (5, 10 and 15 mg) of the new H1-receptor antagonist 3,7-dihydro-7-[2-hydroxy-3-[4-[3-phenylthio) propyl]-1… 
1986
1986
Animal pharmacology of the selective histamine H1-receptor antagonist tazifylline.
3,7-Dihydro-7-[2-hydroxy-3-[4-[3-(phenylthio) propyl]-1-piperazinyl]propyl]-1,3-dimethyl-1H-purine-2,6-dione dihydrochloride… 
1985
1985
New antihistaminic theophylline or theobromine derivatives.
A series of 3,4-dihydro-1,3-dimethyl-7-[3-(4-substituted-piperazin-1-yl)- substituted-alkyl]-1H-purine-2,6-diones and 3,7-dihydro… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)